VHL P2=(c.6C>G) and P81S(c.241C>T)

CI-VAR-00003335Explore in graph →CIViC 4176

Curated evidence

Evidence by cancer (1 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–1 of 1 evidence items across 1 cancer context on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Von Hippel-Lindau Disease1unmapped disease
VHL P2=(c.6C>G) and P81S(c.241C>T)	(predisposing)	Predisposing	C	Supports Predisposition	2	submitted	EID10660 The authors evaluated a family of five VHL c.241C>T (p.Pro81Ser) carriers, as well as the clinical characteristics of all the p.Pro81Ser carriers reported in the literature. Five members of one family… (full text at CIViC) PMID 28503092 · Alosi et al., 2017 · Open in CIViC	civic

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.